Similar articles

• Voriconazole versus amphotericin B for invasive aspergillosis.

  Karthaus M. Karthaus M. N Engl J Med. 2002 Dec 19;347(25):2080-1; author reply 2080-1. N Engl J Med. 2002. PMID: 12494937 No abstract available.
• Strategy of following voriconazole versus amphotericin B therapy with other licensed antifungal therapy for primary treatment of invasive aspergillosis: impact of other therapies on outcome.

  Patterson TF, Boucher HW, Herbrecht R, Denning DW, Lortholary O, Ribaud P, Rubin RH, Wingard JR, DePauw B, Schlamm HT, Troke P, Bennett JE; European Organization for Research and Treatment of Cancer (EORTC) Invasive Fungal Infections Group (IFIG); Pfizer Global Aspergillus Study Group. Patterson TF, et al. Clin Infect Dis. 2005 Nov 15;41(10):1448-52. doi: 10.1086/497126. Epub 2005 Oct 13. Clin Infect Dis. 2005. PMID: 16231256 Clinical Trial.
• Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.

  Herbrecht R, Denning DW, Patterson TF, Bennett JE, Greene RE, Oestmann JW, Kern WV, Marr KA, Ribaud P, Lortholary O, Sylvester R, Rubin RH, Wingard JR, Stark P, Durand C, Caillot D, Thiel E, Chandrasekar PH, Hodges MR, Schlamm HT, Troke PF, de Pauw B; Invasive Fungal Infections Group of the European Organisation for Research and Treatment of Cancer and the Global Aspergillus Study Group. Herbrecht R, et al. N Engl J Med. 2002 Aug 8;347(6):408-15. doi: 10.1056/NEJMoa020191. N Engl J Med. 2002. PMID: 12167683 Clinical Trial.
• Treatment strategies for invasive aspergillosis in neutropenic patients: voriconazole or liposomal amphotericin-B?

  Pagano L, Valentini CG, Fianchi L, Caira M. Pagano L, et al. J Chemother. 2011 Feb;23(1):5-8. doi: 10.1179/joc.2011.23.1.5. J Chemother. 2011. PMID: 21482486 Review.
• Breakthrough invasive pulmonary aspergillosis despite empirical voriconazole therapy for febrile neutropenia: case report and review of the literature.

  Meyer M, Waldvogel S, Chalandon Y, Bongiovanni M, Pache JC, Van Delden C. Meyer M, et al. Scand J Infect Dis. 2007;39(8):731-3. doi: 10.1080/00365540701199857. Scand J Infect Dis. 2007. PMID: 17654353 Review.